Trade Report: The Brokerages Set NantHealth Inc (NYSE:NH) Target Price at $18.00

The Brokerages Set NantHealth Inc (NYSE:NH) Target Price at $18.00

NantHealth Inc (NYSE:NH) has been given an average recommendation of “Buy” by the six brokerages that are currently covering the firm. One research analyst has rated the stock with a sell recommendation and five have issued a buy recommendation on the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $18.00.

A number of equities research analysts have weighed in on the company. Canaccord Genuity reaffirmed a “buy” rating and issued a $17.00 price objective on shares of NantHealth in a report on Monday, September 19th. Zacks Investment Research raised NantHealth from a “sell” rating to a “hold” rating in a report on Friday, September 23rd. Cowen and Company assumed coverage on NantHealth in a report on Monday, June 27th. They issued an “outperform” rating and a $19.00 price objective on the stock. FBR & Co assumed coverage on NantHealth in a report on Monday, June 27th. They issued an “outperform” rating and a $18.00 price objective on the stock. Finally, First Analysis assumed coverage on NantHealth in a report on Monday, June 27th. They issued an “overweight” rating and a $18.00 price objective on the stock.

Shares of NantHealth (NYSE:NH) opened at 13.41 on Wednesday. NantHealth has a 12-month low of $9.79 and a 12-month high of $16.63. The firm’s market cap is $1.63 billion. The company has a 50 day moving average price of $13.11 and a 200 day moving average price of $12.67.

NantHealth (NYSE:NH) last issued its quarterly earnings results on Tuesday, August 9th. The company reported ($0.15) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.41) by $0.26. The company earned $31.50 million during the quarter, compared to analyst estimates of $23.55 million. The business’s revenue was up 166.9% on a year-over-year basis. On average, analysts forecast that NantHealth will post ($0.59) earnings per share for the current fiscal year.

Large investors have recently made changes to their positions in the company. Wildcat Capital Management LLC purchased a new stake in shares of NantHealth during the second quarter valued at approximately $3,008,000. Jefferies Group LLC purchased a new stake in shares of NantHealth during the second quarter valued at approximately $6,943,000. Blackstone Group L.P. purchased a new stake in shares of NantHealth during the second quarter valued at approximately $7,463,000. Finally, FMR LLC purchased a new stake in shares of NantHealth during the second quarter valued at approximately $11,250,000.

Related posts

Leave a Comment